105 related articles for article (PubMed ID: 8381943)
1. Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients.
Frost L; Danielsen H; Dørup I; Kjaer T; Pedersen EB
Nephrol Dial Transplant; 1993; 8(1):79-83. PubMed ID: 8381943
[TBL] [Abstract][Full Text] [Related]
2. Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.
Allegra A; Corica F; Ientile R; Corsonello A; Sparacino V; Accettola F; Caputo F; Macaione S; Buemi M
Magnes Res; 1998 Mar; 11(1):11-8. PubMed ID: 9595545
[TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
[TBL] [Abstract][Full Text] [Related]
4. Serum propeptides of type I and III procollagens in renal transplant recipients. A comparison of cyclosporine and azathioprine treatment.
Heickendorff L; Frost L; Madsen JK; Pedersen EB
Nephron; 1994; 67(2):203-8. PubMed ID: 8072610
[TBL] [Abstract][Full Text] [Related]
5. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.
Markell MS; Altura BT; Barbour RL; Altura BM
Clin Sci (Lond); 1993 Sep; 85(3):315-8. PubMed ID: 8403804
[TBL] [Abstract][Full Text] [Related]
6. Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?
Webb AT; Reaveley DA; O'Donnell M; O'Connor B; Seed M; Brown EA
Lancet; 1993 Jan; 341(8840):268-70. PubMed ID: 8093917
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin-induced renal magnesium leak in renal transplant patients.
Scoble JE; Freestone A; Varghese Z; Fernando ON; Sweny P; Moorhead JF
Nephrol Dial Transplant; 1990; 5(9):812-5. PubMed ID: 2129356
[TBL] [Abstract][Full Text] [Related]
8. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
[TBL] [Abstract][Full Text] [Related]
9. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics.
Dørup I; Skajaa K; Clausen T; Kjeldsen K
Br Med J (Clin Res Ed); 1988 Feb; 296(6620):455-8. PubMed ID: 2450616
[TBL] [Abstract][Full Text] [Related]
10. Triple therapy and incidence of de novo cancer in renal transplant recipients.
Kehinde EO; Petermann A; Morgan JD; Butt ZA; Donnelly PK; Veitch PS; Bell PR
Br J Surg; 1994 Jul; 81(7):985-6. PubMed ID: 7922092
[TBL] [Abstract][Full Text] [Related]
11. Failure to detect remarkable hypomagnesemia in renal transplant recipients receiving ciclosporin.
Haag-Weber M; Schollmeyer P; Hörl WH
Miner Electrolyte Metab; 1990; 16(1):66-8. PubMed ID: 2325594
[TBL] [Abstract][Full Text] [Related]
12. Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients.
al-Khursany I; Thomas TH; Harrison K; Wilkinson R
Nephrol Dial Transplant; 1992; 7(3):251-5. PubMed ID: 1314999
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine induced nephrotoxicity in renal transplant recipients: clinical significance of fractional excretion of sodium, potassium and magnesium.
Naqvi HN; Zafar MN; Hussain A; Naqvi SA; Rizvi AH
J Pak Med Assoc; 2005 Apr; 55(4):161-5. PubMed ID: 15918629
[TBL] [Abstract][Full Text] [Related]
14. Renal handling of magnesium in transplanted children under cyclosporin A treatment.
Krull F; Hoyer PF; Offner G; Brodehl J
Eur J Pediatr; 1988 Nov; 148(2):148-51. PubMed ID: 3069471
[TBL] [Abstract][Full Text] [Related]
15. Myopathy with ragged red fibres following renal transplantation: possible role of cyclosporin-induced hypomagnesaemia.
Larner AJ; Sturman SG; Hawkins JB; Anderson M
Acta Neuropathol; 1994; 88(2):189-92. PubMed ID: 7985501
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus-associated hypomagnesemia in renal transplant recipients.
Navaneethan SD; Sankarasubbaiyan S; Gross MD; Jeevanantham V; Monk RD
Transplant Proc; 2006 Jun; 38(5):1320-2. PubMed ID: 16797291
[TBL] [Abstract][Full Text] [Related]
17. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity.
Holzmacher R; Kendziorski C; Michael Hofman R; Jaffery J; Becker B; Djamali A
Nephrol Dial Transplant; 2005 Jul; 20(7):1456-62. PubMed ID: 15840674
[TBL] [Abstract][Full Text] [Related]
18. Increased serum erythropoietin level during azathioprine treatment in renal transplant recipients.
Jensen JD; Hansen HE; Pedersen EB
Nephron; 1994; 67(3):297-301. PubMed ID: 7936019
[TBL] [Abstract][Full Text] [Related]
19. Long-term calcineurin inhibition and magnesium balance after renal transplantation.
Mazzola BL; Vannini SD; Truttmann AC; von Vigier RO; Wermuth B; Ferrari P; Bianchetti MG
Transpl Int; 2003 Feb; 16(2):76-81. PubMed ID: 12595968
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin-induced hypomagnesaemia and renal magnesium wasting in rats.
Wong NL; Dirks JH
Clin Sci (Lond); 1988 Nov; 75(5):509-14. PubMed ID: 3254764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
